 | ||||||||
| "anti diabetes" | ||||||||
| NEWS | ||||||||
MannKind Looks Good For Long Term Investors However, as an anti-diabetes drug, there are two things about Afrezza that make it a winner in the current market. One is its rapidly acting formulation ...
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.